简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-01-04 10:07 Dr. Xiaoxiang Chen Joins Harbour BioMed as Executive Vice President, Head of Clinical Development and Regulatory Science
2018-01-04 10:04 Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€
2018-01-03 14:26 Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
2018-01-02 18:37 RF IDeas Appoints Nicholas Low as Regional Sales Director for Asia Pacific Region
2017-12-25 18:49 Starr Companies Announces Cooperation with PICC Health to Provide Insurance to Chinese Company Employees Working in the Belt & Road Initiative Countries
2017-12-25 10:03 Clover Biopharmaceuticals Receives CFDA Approval to Initiate Clinical Trials in China with Etanercept Biosimilar Candidate SCB-808
2017-12-22 13:24 Denis DELVAL is Appointed CEO of LFB SA
2017-12-21 14:16 LMD Welcomes ‘Smartphone-as-Medical-Instrument’ Trend and Highlights Need for Clinical Accuracy
2017-12-20 15:16 ABEC Expands Vessel Supply and Service Capability for Global Biopharmaceutical Manufacturers
2017-12-15 15:22 BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
2017-12-15 09:33 Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
2017-12-13 10:06 Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program
2017-12-12 15:58 Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
2017-12-12 09:59 Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
2017-12-11 14:03 Bertin and Zymo Research Announce New Collaboration
2017-12-11 13:26 Herbalife Nutrition Appoints Renowned Thai Sports Medicine Expert to Its Nutrition Advisory Board
2017-12-11 10:26 AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
2017-12-11 10:23 Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
2017-12-11 10:21 AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
2017-12-08 16:24 Herbalife Nutrition Hong Kong and Po Leung Kuk Set New World Record in Launching Healthy Active Lifestyle Mobile App

Business Wire Weibo

Press Releases

Latest Releases